Novel Compounds as PKC-Theta Inhibitors for Treating Autoimmune or Inflammatory Diseases

ACS Medicinal Chemistry Letters 2026 Open access

Read full text
Authors: Ram W. Sabnis
DOI: 10.1021/acsmedchemlett.5c00765
Cited by: 1
References: 4

Abstract

High Resolution Image Download MS PowerPoint Slide Provided herein are novel compounds as PKC-theta inhibitors, pharmaceutical compositions, use of such compounds in treating autoimmune or inflammatory diseases, and processes for preparing such compounds.

Fields of Study & Subjects

Protein Kinase Regulation and GTPase Signaling Neurological Disorders and Treatments Phosphodiesterase function and regulation

Publication details

Journal / source
ACS Medicinal Chemistry Letters
Publisher
American Chemical Society (ACS)
Volume
17
Issue
2
Pages
294–295
Publication date
7 January 2026
Language
EN